You have 9 free searches left this month | for more free features.

Brain Irradiation

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Meningioma, Radiation Toxicity Trial in Caen, Rouen (Normo-fractionated intensity-modulated brain irradiation with or without

Recruiting
  • Meningioma
  • Radiation Toxicity
  • Normo-fractionated intensity-modulated brain irradiation with or without stereotactic positioning
  • +3 more
  • Caen, France
  • +1 more
Sep 13, 2023

Glioblastoma Multiforme Trial in Manchester (Preoperative brain irradiation (single fraction))

Recruiting
  • Glioblastoma Multiforme
  • Preoperative brain irradiation (single fraction)
  • Manchester, Greater Manchester, United Kingdom
    The Christie NHS Foundation Trust
Aug 2, 2022

Intracranial Meningioma Trial in Taoyuan (Radiation)

Not yet recruiting
  • Intracranial Meningioma
  • Radiation
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital
Apr 14, 2023

Metastatic Breast Cancer Trial in New York (Brain radiotherapy or Stereotactic Radiosurgery, Tremelimumab, HER2 directed

Completed
  • Metastatic Breast Cancer
  • Brain radiotherapy or Stereotactic Radiosurgery
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 2, 2022

Alzheimer Trial in Seoul (Low-dose whole brain irradiation)

Recruiting
  • Alzheimer Disease
  • Low-dose whole brain irradiation
  • Seoul, Korea, Republic of
    Kyung Hee University Hospital at Gangdong
Nov 22, 2022

Brain Metastases, Lung Cancer Trial in Duarte, Aurora, Rochester (Brigatinib)

Active, not recruiting
  • Brain Metastases
  • Lung Cancer
  • Duarte, California
  • +2 more
Feb 8, 2022

Prophylactic Cranial Irradiation, Cumulative Incidence of Brain Metastases Trial in Guiyang (Prophylactic Cranial Irradiation

Recruiting
  • Prophylactic Cranial Irradiation, Cumulative Incidence of Brain Metastases
  • Prophylactic Cranial Irradiation for experiment arm
  • Guiyang, Guizhou, China
    Guizhou Cancer Hospital
Aug 23, 2023

Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse Intrinsic Pontine Glioma, Diffuse Glioma Trial (Re-irradiation)

Not yet recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • +5 more
  • Re-irradiation
  • (no location specified)
Oct 16, 2023

Brain Tumor, Low Grade Glioma, Astrocytoma Trial in Boston (Proton radiotherapy)

Active, not recruiting
  • Brain Tumor
  • +4 more
  • Proton radiotherapy
  • Boston, Massachusetts
  • +1 more
Sep 30, 2021

Bladder Cancer Trial in Houston (Prophylactic Cranial Irradiation (PCI), Brain X-ray)

Active, not recruiting
  • Bladder Cancer
  • Prophylactic Cranial Irradiation (PCI)
  • Brain X-ray
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 18, 2022

Small Cell Lung Cancer Limited Stage Trial (Prophylactic cranial irradiation, Thoracic radiotherapy, Chemotherapy)

Not yet recruiting
  • Small Cell Lung Cancer Limited Stage
  • Prophylactic cranial irradiation
  • +2 more
  • (no location specified)
Dec 14, 2022

Metastatic Malignant Tumor in the Brain Trial in Rochester (Questionnaire Administration, Stereotactic Radiosurgery)

Recruiting
  • Metastatic Malignant Neoplasm in the Brain
  • Questionnaire Administration
  • Stereotactic Radiosurgery
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 5, 2023

Recurrent High-grade Glioma, Recurrent Glioblastoma, Recurrent Anaplastic Astrocytoma Trial in Incheon (500mg/kg/3hr followed by

Recruiting
  • Recurrent High-grade Glioma
  • +3 more
  • 500mg/kg/3hr followed by neutron irradiation to reach maximum brain dose of 9Gy-Eq
  • +2 more
  • Incheon, Korea, Republic of
    Gachon University Gil Medical Center
Feb 19, 2023

Neurocognitive Deficit, Quality of Life, Activities of Daily Living Trial in Viagrande, Messina, Palermo (Stereotactic

Recruiting
  • Neurocognitive Deficit
  • +2 more
  • Stereotactic RadioTherapy
  • Whole Brain Irradiation
  • Viagrande, Catania, Italy
  • +3 more
May 13, 2021

Cancer, Brain Metastases, Adult Trial in Copenhagen (Repeated stereotactic radiosurgery)

Recruiting
  • Cancer
  • Brain Metastases, Adult
  • Repeated stereotactic radiosurgery
  • Copenhagen, Denmark
    Rigshospitalet, University of Copenhagen
Nov 8, 2021

Neurocognitive Trial in Guangzhou (Osimertinib and whole-brain irradiation, Osimertinib)

Recruiting
  • Neurocognitive
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Cancer Center of Sun Yat-Sen Uni
Mar 31, 2021

Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial

Recruiting
  • Glioblastoma
  • +8 more
  • Intra-arterial Cetuximab
  • +2 more
  • New York, New York
    Lenox Hill Brain Tumor Center
Oct 17, 2022

Brain Tumors, Adult, Malignant Trial in Dallas (Radiotherapy)

Completed
  • Brain Neoplasms, Adult, Malignant
  • Radiotherapy
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Jan 5, 2021

Recurrent Glioma, Recurrent Glioblastoma, Poly ADP Ribose Polymerase (PARP) Inhibitor Trial in Hong Kong (Talazoparib)

Recruiting
  • Recurrent Glioma
  • +4 more
  • Hong Kong, Hong Kong
    Department of Clinical Oncology
Aug 19, 2021

Metastatic Malignant Tumor in the Brain, Stage IV NSCLC AJCC v7 Trial in Houston (procedure, biological, other, radiation)

Recruiting
  • Metastatic Malignant Neoplasm in the Brain
  • Stage IV Non-Small Cell Lung Cancer AJCC v7
  • Cognitive Assessment
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

Brain and CNS Tumors Trial in Memphis (GDC-0084, radiation therapy)

Completed
  • Brain and Central Nervous System Tumors
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jan 13, 2023

Malignant Tumor, Brain, Brain Tumor Trial in Los Angeles (other, radiation, procedure)

Withdrawn
  • Malignant Neoplasm, Brain
  • Brain Tumor
  • Quality-of-Life Assessment
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jan 14, 2022

Recurrent Brain Tumor Trial in Houston (biological, other, radiation)

Active, not recruiting
  • Recurrent Brain Neoplasm
  • Bevacizumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Metastatic Malignant Tumor in the Brain Trial in

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +6 more
  • Ipilimumab
  • +4 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Dec 12, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Houston

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Quality-of-Life Assessment
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 8, 2022